Skip to content

Clinical trials

Phase 4 Heart Failure trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 4 Country / region: China Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20122
20141
20161
20172
20191
20205
20213
20222
20233
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status12
Completed5
Not yet recruiting3
Recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zhijun Sun3
China National Center for Cardiovascular Diseases2
China-Japan Friendship Hospital2
Chinese Academy of Medical Sciences, Fuwai Hospital2
Dongying Zhang2
Cong-xin Huang1
Hebei Medical University1
Huazhong University of Science and Technology1
McMaster University1
Merck KGaA, Darmstadt, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure25
Aortic Valve Stenosis2
Anemia1
Cardiomyopathies1
Cardiomyopathy, Dilated1
Cardiovascular Diseases1
Heart Neoplasms1
Hyperuricemia1
Inflammation1
Influenza, Human1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.